Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Coit, DG; Thompson, JA; Algazi, A; Andtbacka, R; Bichakjian, CK; Carson, WE; Daniels, GA; DiMaio, D; Ernstoff, M; Fields, RC; Fleming, MD ...
Published in: J Natl Compr Canc Netw
April 2016
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because substantial changes were made to the recommendations for the 2016 update. Depending on the stage of the disease, options for adjuvant therapy now include biochemotherapy and high-dose ipilimumab. Treatment options for in-transit disease now include intralesional injection with talimogene laherparepvec (T-VEC), a new immunotherapy. These additions prompted re-assessment of the data supporting older recommended treatment options for adjuvant therapy and in-transit disease, resulting in extensive revisions to the supporting discussion sections.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2016
Volume
14
Issue
4
Start / End Page
450 / 473
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Melanoma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., … Engh, A. (2016). Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 14(4), 450–473. https://doi.org/10.6004/jnccn.2016.0051
Coit, Daniel G., John A. Thompson, Alain Algazi, Robert Andtbacka, Christopher K. Bichakjian, William E. Carson, Gregory A. Daniels, et al. “Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 14, no. 4 (April 2016): 450–73. https://doi.org/10.6004/jnccn.2016.0051.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, et al. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Apr;14(4):450–73.
Coit, Daniel G., et al. “Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 14, no. 4, Apr. 2016, pp. 450–73. Pubmed, doi:10.6004/jnccn.2016.0051.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Apr;14(4):450–473.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2016
Volume
14
Issue
4
Start / End Page
450 / 473
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Melanoma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis